Are JAK inhibitors (specifically tofacitinib or ruxolitinib) an effective treatment option for alopecia areata?
Featuring Seemal Desai, MD | Education Advisor |
Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX
Related CME
Related Media
Powered by Polaris TM